HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hee Jin Lee Selected Research

High Mobility Group Proteins

9/2016Endoplasmic reticulum stress induces secretion of high-mobility group proteins and is associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.
12/2015High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hee Jin Lee Research Topics

Disease

63Neoplasms (Cancer)
12/2022 - 07/2007
56Breast Neoplasms (Breast Cancer)
10/2022 - 06/2011
18Triple Negative Breast Neoplasms
06/2021 - 01/2014
9Neoplasm Metastasis (Metastasis)
12/2022 - 06/2014
5Carcinoma (Carcinomatosis)
08/2016 - 02/2013
5Adenocarcinoma
11/2014 - 08/2011
4Carcinogenesis
01/2021 - 10/2014
4Pathologic Complete Response
11/2020 - 06/2014
4Residual Neoplasm
11/2020 - 05/2014
4Tertiary Lymphoid Structures
01/2019 - 08/2015
3Inflammation (Inflammations)
01/2021 - 04/2014
3Noninfiltrating Intraductal Carcinoma (DCIS)
12/2020 - 11/2013
3Testicular Neoplasms (Testicular Cancer)
01/2015 - 01/2015
2Circulating Neoplastic Cells
03/2021 - 10/2020
2Hip Fractures (Intertrochanteric Fractures)
10/2017 - 03/2017
2Arthritis (Polyarthritis)
01/2017 - 04/2014
2Cataract (Cataracts)
05/2016 - 04/2015
2Endometrial Neoplasms (Endometrial Cancer)
01/2015 - 11/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 01/2013
2Multiple Myeloma
07/2007 - 06/2006
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Renal Cell Carcinoma (Grawitz Tumor)
01/2022
1Cardiotoxicity
01/2021

Drug/Important Bio-Agent (IBA)

16Hormones (Hormone)IBA
12/2020 - 07/2008
13Biomarkers (Surrogate Marker)IBA
02/2021 - 10/2012
12Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2007
12human ERBB2 proteinIBA
10/2022 - 06/2011
9Trastuzumab (Herceptin)FDA Link
08/2021 - 06/2014
8Estrogen ReceptorsIBA
10/2022 - 10/2014
7MicroRNAs (MicroRNA)IBA
01/2018 - 11/2012
6InterferonsIBA
10/2022 - 04/2016
6RNA (Ribonucleic Acid)IBA
12/2020 - 06/2016
4HLA Antigens (Human Leukocyte Antigens)IBA
10/2022 - 04/2016
4ErbB Receptors (EGF Receptor)IBA
08/2021 - 11/2012
4Formaldehyde (Formol)FDA Link
12/2020 - 06/2011
4ParaffinIBA
12/2020 - 06/2011
4AntigensIBA
01/2020 - 01/2015
4Biological ProductsIBA
12/2017 - 06/2014
4Phenobarbital (Luminal)FDA Link
04/2017 - 05/2014
3EnzymesIBA
01/2021 - 09/2013
3Lapatinib (GW572016)FDA Link
10/2020 - 10/2016
3HMGB1 Protein (HMG1)IBA
01/2019 - 12/2015
3taxaneIBA
03/2018 - 01/2015
3CytokinesIBA
05/2016 - 01/2015
3Cadherins (E-Cadherin)IBA
08/2014 - 02/2013
2ChemokinesIBA
12/2022 - 01/2020
2Estrogens (Estrogen)FDA Link
10/2022 - 01/2014
2B7-H1 AntigenIBA
06/2021 - 11/2020
2Dinoprostone (PGE2)FDA Link
01/2021 - 05/2016
2Progesterone Receptors (Progesterone Receptor)IBA
11/2020 - 10/2014
2Messenger RNA (mRNA)IBA
11/2020 - 07/2016
2Immune Checkpoint InhibitorsIBA
11/2020 - 01/2020
2Interferon-gamma (Interferon, gamma)IBA
11/2020 - 01/2017
2Epidermal Growth Factor (EGF)IBA
10/2020 - 06/2014
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2020 - 06/2015
2Letrozole (Femara)FDA LinkGeneric
10/2020 - 10/2016
2Sirtuin 1IBA
07/2019 - 01/2016
2HMGN1 Protein (HMGN1)IBA
01/2019 - 12/2015
2Protein Kinases (Protein Kinase)IBA
01/2017 - 06/2016
2Heme Oxygenase-1IBA
01/2017 - 04/2014
2High Mobility Group ProteinsIBA
09/2016 - 12/2015
2Phosphotransferases (Kinase)IBA
06/2016 - 08/2014
2HLA-A Antigens (HLA-A)IBA
05/2016 - 08/2015
2Interleukin-6 (Interleukin 6)IBA
05/2016 - 01/2015
2AntioxidantsIBA
04/2015 - 04/2014
2AnthracyclinesIBA
02/2015 - 01/2015
2SilverIBA
12/2014 - 06/2011
2VimentinIBA
08/2014 - 11/2013
2CateninsIBA
11/2013 - 02/2013
2pleiotrophin (HARP)IBA
07/2007 - 06/2006
1P-SelectinIBA
12/2022
1Epithelial Cell Adhesion MoleculeIBA
12/2022
1LigandsIBA
12/2022
1Interleukin-8 (Interleukin 8)IBA
12/2022
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2022
1Collagenases (Collagenase)FDA Link
01/2022
1ProteomeIBA
12/2021
1Amsacrine (AMSA)IBA
12/2021
1Docetaxel (Taxotere)FDA Link
08/2021
1pertuzumabIBA
08/2021
1Carboplatin (JM8)FDA LinkGeneric
08/2021
1atezolizumabIBA
06/2021
1Prostaglandin D2IBA
01/2021
1EicosanoidsIBA
01/2021
1ThromboxanesIBA
01/2021
1LeukotrienesIBA
01/2021
1AntagomirsIBA
01/2021
1ProstaglandinsIBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1Androgen Receptors (Androgen Receptor)IBA
12/2020
1Histone Deacetylase 1IBA
12/2020

Therapy/Procedure

17Therapeutics
11/2020 - 02/2012
15Neoadjuvant Therapy
10/2022 - 03/2013
7Immunotherapy
12/2021 - 01/2015
5Drug Therapy (Chemotherapy)
07/2019 - 06/2014
3Mastectomy (Mammectomy)
01/2022 - 09/2013
3Adjuvant Chemotherapy
10/2015 - 06/2015
1Simple Mastectomy
01/2022
1Mammaplasty (Breast Reconstruction)
01/2022